Ares Capital Corporation filings document the regulatory record of a closed-ended specialty finance company with common stock listed on the Nasdaq Global Select Market. Its periodic and current reports disclose operating results, financial condition, dividend declarations, portfolio measures, leverage, and capital-structure activity tied to its investment portfolio.
The company’s Form 8-K filings include financial results releases, material definitive agreements, equity distribution agreements, funding facility amendments and note indenture disclosures. Proxy materials cover annual meeting matters, director elections and auditor ratification, while related vote-result filings record stockholder approvals and governance outcomes.
Ares Capital Corporation held a special meeting where shareholders authorized the board to sell or issue common stock at a price below the company's then-current net asset value per share, subject to limits. The authorization limits any such issuance to no more than 25% of outstanding common shares and is effective for a 12-month period expiring on August 8, 2026. The record date for voting showed 694,181,754 shares outstanding.
The inspector certified the vote: among all holders, 286,084,869 voted for, 63,903,043 against and 11,635,163 abstained. Excluding affiliated persons, the for vote was 279,483,225. The approval gives the board short-term flexibility to issue up to a capped amount of shares below NAV; it was adopted with clear but not unanimous support.